In Silico Insight Into EGFR Treatment in Patients With Lung Carcinoma and T790M Mutations

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2017.4168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

Oncology Reports
MedicineCancer ResearchOncology
2014English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery
Oncology
2014English

OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients With EGFR Activating and T790M Mutations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

C797S and T790M EGFR Mutations in Non–Small Cell Lung Cancer: In Trans or in Separate Clones?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma

Annals of Surgical Oncology
OncologySurgery
2017English

Activation of the BMP-BMPR Pathway Conferred Resistance to EGFR-TKIs in Lung Squamous Cell Carcinoma Patients With EGFR Mutations

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

EGFR T790M Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Lung Adenocarcinoma Patients With Acquired Resistance to First Generation EGFR Tyrosine Kinase Inhibitors

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2018English

Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma With G719S, S768I, and T790M Mutations

Internal Medicine
Internal MedicineMedicine
2018English

EGFR With TKI-sensitive Mutations in Exon 19 Is Highly Expressed and Frequently Detected in Chinese Patients With Lung Squamous Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy